BioHarvest Sciences Inc. Files November 2024 6-K Report

Ticker: BHST · Form: 6-K · Filed: Nov 12, 2024

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer

TL;DR

BHSC filed its Nov 2024 6-K, standard foreign private issuer update.

AI Summary

BioHarvest Sciences Inc. filed a Form 6-K on November 12, 2024, reporting for the month of November 2024. The company, previously known as Canna-V-Cell Sciences Inc. and Midnight Star Ventures Corp., is incorporated in A1 and has its principal executive offices in Vancouver, British Columbia, Canada. This filing is a report of a foreign private issuer.

Why It Matters

This filing provides an update on BioHarvest Sciences Inc.'s status as a foreign private issuer, which is relevant for investors tracking regulatory disclosures and company operations.

Risk Assessment

Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information that would inherently increase risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer would be required to make public pursuant to the laws of its home country.

When was BioHarvest Sciences Inc. previously known by other names?

BioHarvest Sciences Inc. was formerly known as Canna-V-Cell Sciences Inc. (name change effective October 8, 2019) and Midnight Star Ventures Corp. (name change effective November 21, 2017).

Where are BioHarvest Sciences Inc.'s principal executive offices located?

The principal executive offices of BioHarvest Sciences Inc. are located at 1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada.

Does BioHarvest Sciences Inc. file annual reports on Form 20-F or 40-F?

BioHarvest Sciences Inc. indicates it files annual reports under cover of Form 20-F.

What is the SIC code for BioHarvest Sciences Inc.?

The Standard Industrial Classification (SIC) code for BioHarvest Sciences Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 204 words · 1 min read · ~1 pages · Grade level 18 · Accepted 2024-11-12 15:18:03

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: November 12, 2024 /s/ David Ryan Name: David Ryan Title: Vice-President, Investor Relations & Secretary

View on Read The Filing